BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 2079081)

  • 1. Clinical Features, Treatment, and Prognostic Factors of Childhood-Onset Myasthenia Gravis in a Large Chinese Cohort.
    Bi Z; Ge H; Zhang Q; Gao H; Yang M; Zhan J; Lin J; Gui M; Li Y; Ji S; Cao Y; Bu B
    Pediatr Neurol; 2023 Sep; 146():31-39. PubMed ID: 37421800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome after Robotic-Assisted Thymectomy in Children and Adolescents with Acetylcholine Receptor Antibody-Positive Juvenile Myasthenia Gravis.
    Della Marina A; Kölbel H; Müllers M; Kaiser O; Ismail M; Swierzy M; Rueckert JC; Schara U
    Neuropediatrics; 2017 Aug; 48(4):315-322. PubMed ID: 28628938
    [No Abstract]   [Full Text] [Related]  

  • 3. Response to treatment in pediatric ocular myasthenia gravis.
    Xu L; Castro D; Reisch JS; Iannaccone ST
    Muscle Nerve; 2020 Feb; 61(2):226-230. PubMed ID: 31650555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency and clinical features of treatment-refractory myasthenia gravis.
    Rath J; Brunner I; Tomschik M; Zulehner G; Hilger E; Krenn M; Paul A; Cetin H; Zimprich F
    J Neurol; 2020 Apr; 267(4):1004-1011. PubMed ID: 31828474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Juvenile myasthenia gravis in Norway: Clinical characteristics, treatment, and long-term outcome in a nationwide population-based cohort.
    Popperud TH; Boldingh MI; Rasmussen M; Kerty E
    Eur J Paediatr Neurol; 2017 Sep; 21(5):707-714. PubMed ID: 28457757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of Preoperative and Postoperative Corticosteroid Therapies in Myasthenia Gravis.
    Jing Y; Liu X; Yu L; Li R
    Eur Neurol; 2017; 78(1-2):86-92. PubMed ID: 28738395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The clinical characteristics of early-onset versus late-onset types of myasthenia gravis].
    Wang W; Chen YP; Wei DN
    Zhonghua Nei Ke Za Zhi; 2011 Jun; 50(6):496-8. PubMed ID: 21781535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Biomarker Strategies in Autoimmune Neuromuscular Diseases.
    Oeztuerk M; Henes A; Schroeter CB; Nelke C; Quint P; Theissen L; Meuth SG; Ruck T
    Cells; 2023 Oct; 12(20):. PubMed ID: 37887300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thoracoscopic thymectomy for juvenile myasthenia gravis.
    Kim AG; Upah SA; Brandsema JF; Yum SW; Blinman TA
    Pediatr Surg Int; 2019 May; 35(5):603-610. PubMed ID: 30729982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Juvenile myasthenia gravis in Norway: HLA-DRB1*04:04 is positively associated with prepubertal onset.
    Popperud TH; Viken MK; Kerty E; Lie BA
    PLoS One; 2017; 12(10):e0186383. PubMed ID: 29036181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anaesthetic considerations in paediatric myasthenia gravis.
    Masters OW; Bagshaw ON
    Autoimmune Dis; 2011; 2011():250561. PubMed ID: 21961057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuromuscular junctional disorders.
    Girija AS; Ashraf VV
    Indian J Pediatr; 2008 Jul; 75(7):699-702. PubMed ID: 18716738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoadsorption plasmapheresis for severe generalised myasthenia gravis.
    Ichikawa M; Koh CS; Hata Y; Tohyama M; Tsuno T; Komiyama A
    Arch Dis Child; 1993 Aug; 69(2):236-8. PubMed ID: 8215529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early-onset myasthenia gravis: clinical characteristics and response to therapy.
    Batocchi AP; Evoli A; Palmisani MT; Lo Monaco M; Bartoccioni M; Tonali P
    Eur J Pediatr; 1990 Nov; 150(1):66-8. PubMed ID: 2079081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myasthenia gravis in Jamaican children: a 12-year institutional review.
    Melbourne Chambers R; Forrester S; Gray R; Tapper J; Trotman H
    Paediatr Int Child Health; 2012 Feb; 32(1):47-50. PubMed ID: 22525448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term prednisone followed by thymectomy in myasthenia gravis.
    Mann JD; Johns TR; Campa JF; Muller WH
    Ann N Y Acad Sci; 1976; 274():608-22. PubMed ID: 1066998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of generalized disease at 2 years in patients with ocular myasthenia gravis.
    Kupersmith MJ; Latkany R; Homel P
    Arch Neurol; 2003 Feb; 60(2):243-8. PubMed ID: 12580710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective treatment of infantile myasthenia gravis by combined prednisone and thymectomy.
    Sarnat HB; McGarry JD; Lewis JE
    Neurology; 1977 Jun; 27(6):550-3. PubMed ID: 559263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of juvenile myasthenia gravis.
    Ionita CM; Acsadi G
    Pediatr Neurol; 2013 Feb; 48(2):95-104. PubMed ID: 23337001
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.